spacer
home > ict > autumn 2017 > helping hands
PUBLICATIONS
International Clinical Trials

Helping Hands

To be able to discuss how site nursing support benefits
the clinical trial industry and home care in particular, the
ongoing obstacles need to be understood. Clinical trial sites
face many challenges, such as engaging minority groups
efficiently and quickly identifying patients, while coping
with increased work load due to the small pool of available
research locations.

Equal Representation

One barrier that continues to impact clinical trials is the
enrolment of ethnic minority groups. These classes remain
underrepresented in treatment experiments that could
save their lives. However, some diseases are more prevalent
in different racial and ethnic groups – African Americans
are approximately 70% more likely to be diagnosed with
diabetes, for example (1). Therefore, to produce a drug
that will best treat these patients they must be included
in clinical trials.

This remains an obstacle for several reasons: a lack of
minority principal investigators (PI), a lack of awareness
of clinical trials among these groups or patients living too
far from an enrolling location.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Helena Baker is Vice President of Nursing at Medical Research Network and has over 32 years’ experience in nursing and healthcare. She previously worked at the Royal London Hospital in Whitechapel, Ferring Pharmaceuticals Ltd and St Bartholomew’s Hospital in the UK, as well as acting as a healthcare analyst to the pharmaceutical industry.
spacer
Helena Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IONTAS announces a new collaboration to identify novel immunotherapy targets

Cambridge, UK, 07 May 2020: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Inotrem, a specialist in immunotherapy for acute and chronic inflammatory syndromes. As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.
More info >>

White Papers

Financial implications of off-site visits in clinical research, perception versus reality

Illingworth Research

The concept of patient centricity is still relatively new within clinical trials. For too long, the most important person in the trial has been overlooked… the patient. Here, we explore the benefits of conducting a more patient-centric trial for the patient, site and sponsor through mobile, or ‘off-site’ visits. These advantages are much greater than purely financial, although the financial implications of running a more patient-focused clinical trial may previously have deterred some from this approach. Home nursing in clinical trials continues to be thought of as a high value “premium” service, which many sponsors decline in an attempt to remain within budget for the trial. However, is the actual cost of off-site nursing more expensive than the traditional site model?
More info >>

 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement